1097 related articles for article (PubMed ID: 19369452)
21. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
[TBL] [Abstract][Full Text] [Related]
22. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
[TBL] [Abstract][Full Text] [Related]
23. The minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36.
Colangelo KJ; Pope JE; Peschken C
J Rheumatol; 2009 Oct; 36(10):2231-7. PubMed ID: 19723907
[TBL] [Abstract][Full Text] [Related]
24. The quality of eight health status measures were compared for chronic opioid dependence.
Nosyk B; Sun H; Guh DP; Oviedo-Joekes E; Marsh DC; Brissette S; Schechter MT; Anis AH
J Clin Epidemiol; 2010 Oct; 63(10):1132-44. PubMed ID: 20236799
[TBL] [Abstract][Full Text] [Related]
25. Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: results from the scleroderma lung study.
Khanna D; Yan X; Tashkin DP; Furst DE; Elashoff R; Roth MD; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; Clements PJ;
Arthritis Rheum; 2007 May; 56(5):1676-84. PubMed ID: 17469162
[TBL] [Abstract][Full Text] [Related]
26. Validation of the EQ-5D in patients with a history of acute coronary syndrome.
Ellis JJ; Eagle KA; Kline-Rogers EM; Erickson SR
Curr Med Res Opin; 2005 Aug; 21(8):1209-16. PubMed ID: 16083530
[TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age.
Rinaldi S; Doria A; Salaffi F; Ermani M; Iaccarino L; Ghirardello A; Zampieri S; Sarzi-Puttini P; Gambari PF; Perini G
Rheumatology (Oxford); 2004 Dec; 43(12):1574-9. PubMed ID: 15353611
[TBL] [Abstract][Full Text] [Related]
28. The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].
Chaiamnuay S; Bertoli AM; Fernández M; Apte M; Vilá LM; Reveille JD; Alarcón GS;
J Clin Rheumatol; 2007 Jun; 13(3):128-33. PubMed ID: 17551377
[TBL] [Abstract][Full Text] [Related]
29. Extension from inpatients to outpatients: validity and reliability of the Oxford Knee Score in measuring health outcomes in patients with knee osteoarthritis.
Xie F; Ye H; Zhang Y; Liu X; Lei T; Li SC
Int J Rheum Dis; 2011 May; 14(2):206-10. PubMed ID: 21518321
[TBL] [Abstract][Full Text] [Related]
30. Is there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?
Touma Z; Gladman DD; Ibañez D; Urowitz MB
J Rheumatol; 2011 Sep; 38(9):1898-905. PubMed ID: 21724700
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years.
Barton GR; Sach TH; Avery AJ; Jenkinson C; Doherty M; Whynes DK; Muir KR
Health Econ; 2008 Jul; 17(7):815-32. PubMed ID: 17893863
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.
Grootscholten C; Snoek FJ; Bijl M; van Houwelingen HC; Derksen RH; Berden JH;
J Rheumatol; 2007 Aug; 34(8):1699-707. PubMed ID: 17659757
[TBL] [Abstract][Full Text] [Related]
33. Assessment of disease activity and quality of life in systemic lupus erythematosus - New aspects.
Yee CS; McElhone K; Teh LS; Gordon C
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):457-67. PubMed ID: 19591777
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.
Chen HH; Chen DY; Chen YM; Lai KL
Clin Rheumatol; 2017 Jan; 36(1):133-142. PubMed ID: 27837342
[TBL] [Abstract][Full Text] [Related]
35. The Rheumatology Attitudes Index and its helplessness subscale are valid and reliable measures of learned helplessness in Asian patients with systemic lupus erythematosus.
Thumboo J; Fong KY; Chan SP; Leong KH; Feng PH; Thio ST; Boey ML
J Rheumatol; 1999 Jul; 26(7):1512-7. PubMed ID: 10405938
[TBL] [Abstract][Full Text] [Related]
36. Validation of the EQ-5D questionnaire in burn injured adults.
Oster C; Willebrand M; Dyster-Aas J; Kildal M; Ekselius L
Burns; 2009 Aug; 35(5):723-32. PubMed ID: 19297100
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the psychometric properties of health-related quality of life measures used in adults with systemic lupus erythematosus: a review of the literature.
Castelino M; Abbott J; McElhone K; Teh LS
Rheumatology (Oxford); 2013 Apr; 52(4):684-96. PubMed ID: 23264550
[TBL] [Abstract][Full Text] [Related]
38. Patient-reported impact of urinary incontinence--results from treatment seeking women in 14 European countries.
Monz B; Pons ME; Hampel C; Hunskaar S; Quail D; Samsioe G; Sykes D; Wagg A; Papanicolaou S
Maturitas; 2005 Nov; 52 Suppl 2():S24-34. PubMed ID: 16297579
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the EQ-5D and SF-6D across seven patient groups.
Brazier J; Roberts J; Tsuchiya A; Busschbach J
Health Econ; 2004 Sep; 13(9):873-84. PubMed ID: 15362179
[TBL] [Abstract][Full Text] [Related]
40. Health-related quality of life in systemic lupus erythematosus and its association with disease and work disability.
Almehed K; Carlsten H; Forsblad-d'Elia H
Scand J Rheumatol; 2010; 39(1):58-62. PubMed ID: 20132072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
